Massachusetts Gov. Patrick Duval (D) has signed into law a bill (H. 4235) that will impose on compounding pharmacies new licensing, labeling, education, and oversight requirements, as well as penalties and fines for pharmacies failing to comply. Passed unanimously in the House and Senate in the wake of a fungal meningitis outbreak linked to a compounding pharmacy in Framingham, the new law establishes licensing for sterile, complex non-sterile, hospital, and out-of-state pharmacies, requires reporting of adverse drug events, and eliminates any “gray area” between manufacturing and compounding, among other matters. According to the governor, “Every patient deserves to know that the medication they are taking is safe. This law gives Massachusetts the strength and flexibility to better oversee compounding pharmacy practice and protect patients.” The law will give the commonwealth’s Board of Pharmacy the ability to levy fines of up to $25,000 on violators and the authority to conduct random inspections. See Gov. Patrick Duval Press Release, July 10, 2014.